eISSN: 1897-4309
ISSN: 1428-2526
Contemporary Oncology/Współczesna Onkologia
Current issue Archive Manuscripts accepted About the journal Supplements Addendum Special Issues Abstracting and indexing Subscription Contact Instructions for authors
SCImago Journal & Country Rank
vol. 14
Review paper

Obesity and breast cancer

Małgorzata Mazur-Roszak, Maria Litwiniuk, Sylwia Grodecka-Gazdecka

Współczesna Onkologia (2010) vol. 14;4 (270-275)
Online publish date: 2010/09/09
View full text
Get citation
JabRef, Mendeley
Papers, Reference Manager, RefWorks, Zotero
Obesity is described as pathological enlargement of adipose tissue. It causes metabolic disorders and organ failure and increases risk of many kinds of cancers. BMI > 25 mg/m2 and low physical activity are associated with breast cancer pathogenesis. Insulin represents a major link between obesity and breast cancer; it not only participates in metabolic changes, but is also a well known mitogen. Adipocytes secrete leptin and adiponectin, which are important risk factors for breast cancer. Obese women show high leptin and low adiponectin levels. Decreased adiponectin level correlates with breast cancer risk. Obese patients tend to have non-palpable tumours, that can delay breast cancer diagnosis and worsen treatment prognosis. Therefore it is necessary to educate patients how to change their lifestyle, including adequate physical activity and diet.

obesity, physical activity, breast cancer


Hjartaker A, Langseth H, Weiderprass E. Obesity and diabetes epidemics: cancer repercussions. Adv Exp Med Biol 2008; 630: 72-93.  

Renehan AG, Roberts DL, Dive C. Obesity and cancer: pathophysiological and biological mechanisms. Arch Physiol Biochem 2008; 114: 71-83.  

. Pischon T, Nóthlinhs U, Boening H. Obesity and cancer. Proc Nutr Soc 2008; 67: 128-45.  

Jee SH, Yun JE, Park EJ, Cho ER, Park IS, Sull JW, Ohrr H, Samet JM. Body mass index and cancer risk in Korean men and women. Int J Cancer 2008; 123: 1892-6.  

Song YM, Sung J, Ha M. Obesity and risk of cancer in postmenopausal Korean women. J Clin Oncol 2008; 26: 3395-402.

Begum P, Richardson CE, Carmichael AR. Obesity in post menopausal women with a family history of breast cancer: prevalence and risk awareness. Int Semin Surg Oncol 2009; 6: 1.  

Vainio H, Bianchini F. Physical activity and cancer prevention – is no’ pain, no gain passe? Eur J Cancer Prev 2001; 10: 301-2.  

Lee I, Oguma Y. Physical activity. In: Schottenfeld D, Fraumeni JF. Cancer Epidemiology and Prevention. 3rd ed. Oxford University Press, New York 2006.  

Xue F, Michels KB. Diabetes, metabolic syndrome, and breast cancer: a review of the current evidence. Am J Clin Nutr 2007; 86: 823-35.

Neilson HK, Friedenreich CM, Brockton NT, Millikan RC. Physical activity and postmenopausal breast cancer: proposed biologic mechanisms and areas for future research. Cancer Epidemiol Biomarkers Prev 2009; 18: 11-27.

Goodwin PJ, Ennis M, Bahl M, Fantus IG, Pritchard KI, Trudeau ME, Koo J, Hood N. High insulin levels in newly diagnosed breast cancer patients reflect underlying insulin resistance and are associated with components of the insulin resistance syndrome. Breast Cancer Res Treat 2009; 114: 517-25.

. Montazeri A, Sadighi J, Farzadi F, et al. Weight, height, body mass index and risk of breast cancer in postmenopausal women: a case-control study. BMC Cancer 2008; 8: 278.

Vainio H, Bianchini F. Evaluation of cancer-preventive agents and strategies a new program at the International Agency for Research on Cancer. Ann N Y Acad Sci 2001; 952: 177-80.

van den Brandt PA, Spiegelman D, Yuan SS, et al. Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk. Am J Epidemiol 2000; 152: 514-27.

Trentham-Dietz A, Newcomb PA, Storer BE, Longnecker MP, Baron J, Greenberg ER, Willett WC. Body size and risk of breast cancer. Am J Epidemiol 1997; 145: 1011-9.

Huang Z, Hankinson SE, Cloditz GA, et al. Dual effects of weight and weight gain on breast cancer risk. JAMA 1997; 278: 1407-11.

. Cui Y, Whiteman MK, Flaws JA, Langenberg P, Tkaczuk KH, Bush TL. Body mass and stage of breast cancer at diagnosis. Int J Cancer 2002; 98: 279-83.

Friedenreich CM. Review of anthropometric factors and breast cancer risk. Eur J Cancer Prev 2001; 10: 15-32.

Yoo K, Tajima K, Park S, Kang D, Kim S, Hirose K, Takeuchi T, Miura S. Postmenopausal obesity as a breast cancer risk factor according to estrogen and progesterone receptor status (Japan). Cancer Lett 2001; 167: 57-63.

Dal Maso L, Zucchetto A, Talamini R, Serraino D, Stocco CF, Vercelli M, Falcini F, Franceschi S; Prospective Analysis of Case-control studies on Environmental factors and health (PACE) study group. Effect of obesity and other lifestyle factors on mortality in women with breast cancer. Int J Cancer 2008; 123: 2188-94.

McTiernan A. Cancer Prevention and Management Through Exercise and Weight Control. Boca Raton: Taylor & Francis Group, LLC, 2006.

Holmes MD, Chen WY, Feskanich D, Kroenke CH, Colditz GA. Physical activity and survival after breast cancer diagnosis. JAMA 2005; 293: 2479-86.

. Pinto BM, Frierson GM, Rabin C, Trunzo JJ, Marcus BH. Home-based physical activity intervention for breast cancer patients. J Clin Oncol 2005; 23: 3577-87.

Petrelli JM, Calle EE, Rodriguez C, Thun MJ. Body mass index, height, and postmenopausal breast cancer mortality in a prospective cohort of US women. Cancer Causes Control 2002; 13: 325-32.

Yumuk PF, Dane F, Yumuk VD, et al. Impact of body mass index on cancer development. J BUON 2008; 13: 55-9.

Demirkan B, Alacacioglu A, Yilmaz U. Relation of body mass index (BMI) to disease free (DFS) and distant disease free survivals (DDFS) among Turkish women with operable breast carcinoma. Jpn J Clin Oncol 2007; 37: 256-65.

Cohen SS, Palmieri RT, Nyante SJ, Koralek DO, Kim S, Bradshaw P, Olshan AF. Obesity and screening for breast, cervical, and colorectal cancer in women: a review. Cancer 2008; 112: 1892-904.

Rose DP, Haffner SM, Baillargeon J. Adiposity, the metabolic syndrome, and breast cancer in African-American and white American women. Endocr Rev 2007; 28: 763-77.

. Borgquist S, Djerbi S, Pontén F, et al. HMG-CoA reductase expression in breast cancer is associated with a less aggressive phenotype and influenced by anthropometric factors. Int J Cancer 2008; 123: 1146-53.

Sauter ER, Scott S, Hewett J, Kliethermes B, Ruhlen RL, Basarakodu K, de la Torre R. Biomarkers associated with breast cancer are associated with obesity. Cancer Detect Prev 2008; 32: 149-55.

Bruning PF, Bonfr?r JM, van Noord PA, Hart AA, de Jong-Bakker M, Nooijen WJ. Insulin resistance and breast-cancer risk. Int J Cancer 1992; 52: 511-6.

Frasca F, Pandini G, Sciacca L, Pezzino V, Squatrito S, Belfiore A, Vigneri R. The role of insulin receptors and IGF-I receptors in cancer and other diseases. Arch Physiol Biochem 2008; 114: 23-37.

Jackson JG, White MF, Yee D. Insulin receptor substrate-1 is the predominant signalling molecule activated by insulin- like growth factor-1, insulin and interleukin-4 in estrogen receptor-positive human breast cancer cells. J Biol Chem 1998; 273: 9994-10003.

Goodwin PJ, Ennis M, Pritchard KI, et al. Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study. J Clin Oncol 2002; 20: 42-51.

Gunter MJ, Hoover DR, Yu H, et al. Insulin, insulin-like growth factor-I, and risk of breast cancer in postmenopausal women. J Natl Cancer Inst 2009; 101: 48-60.

Prasad NK, Tandon M, Handa A, Moore GE, Babbs CF, Snyder PW, Bose S. High expression of obesity-linked phosphatase SHIP2 in invasive breast cancer correlates with reduced disease-free survival. Tumour Biol 2008; 29: 330-41.

Goodwin PJ, Pritchard KI, Ennis M, Clemons M, Graham M, Fantus IG. Insulin-lowering effects of metformin in women with early breast cancer. Clin Breast Cancer 2008; 8: 501-5.

Perrier S, Caldefie-Chézet F, Vasson MP. IL-1 family in breast cancer: potential interplay with leptin and other adipocytokines. FEBS Lett 2009; 583: 259-65.

Perera CN, Chin HG, Duru N, Camarillo IG. Leptin-regulated gene expression in MCF-7 breast cancer cells: mechanistic insights into leptin-regulated mammary tumor growth and progression. J Endocrinol 2008; 199: 221-33.

Bartella V, Cascio S, Fiorio E, Auriemma A, Russo A, Surmacz E. Insulin-dependent leptin expression in breast cancer cells. Cancer Res 2008; 68: 4919-27.

Cascio S, Bartella V, Auriemma A, Johannes GJ, Russo A, Giordano A, Surmacz E. Mechanism of leptin expression in breast cancer cells: role of hypoxia-inducible factor-1 alpha. Oncogene 2008; 27: 540-7.

Dogan S, Hu X, Zhang Y, Maihle NJ, Grande JP, Cleary MP. Effects of high-fat diet and/or body weight on mammary tumor leptin and apoptosis signaling pathways in MMTV-TGF-alpha mice. Breast Cancer Res 2007; 9: R91.

Liu CL, Chang YC, Cheng SP, Chern SR, Yang TL, Lee JJ, Guo IC, Chen CP. The roles of serum leptin concentration and polymorphism in leptin receptor gene at codon 109 in breast cancer. Oncology 2007; 72: 75-81.

. Tian YF, Chu CH, Wu MH, et al. Anthropometric measures, plasma adiponectin, and breast cancer risk. Endocr Relat Cancer 2007; 14: 669-77.

Dos Santos E, Benaitreau D, Dieudonne MN, Leneveu MC, Serazin V, Giudicelli Y, Pecquery R. Adiponectin mediates an antiproliferative response in human MDA-MB 231 breast cancer cells. Oncol Rep 2008; 20: 971-7.

Vona-Davis L, Rose DP. Adipokines as endocrine, paracrine, and autocrine factors in breast cancer risk and progression. Endocr Relat Cancer 2007; 14: 189-206.

Karaduman M, Bilici A, Ozet A, Sengul A, Musabak U, Alomeroglu M. Tissue levels of adiponectin in breast cancer patients. Med Oncol 2007; 24: 361-6.

Majed B, Moreau T, Senouci K, Salmon RJ, Fourquet A, Asselain B. Is obesity an independent prognosis factor in women breast cancer? Breast Cancer Res Treat 2008; 111: 329-42.

Chagpar AB, Mc Masters KM, Saul J, et al. Body mass index influences palpability but not stage of breast cancer at diagnosis. Am Surg 2007; 73: 555-60.

Majed B, Moreau T, Asselain B. Overweight, obesity and breast cancer prognosis: optimal body size indicator cut-points. Breast Cancer Res Treat 2009; 115: 193-203.

. Dawood S, Broglio K, Gonzalez-Angulo AM, Kau SW, Islam R, Hortobagyi GN, Cristofanilli M. Prognostic value of body mass index in locally advanced breast cancer. Clin Cancer Res 2008; 14: 1718-25.

Vazquez-Martin A, Ortega-Delgado FJ, Fernandez-Real JM, Menendez JA. The tyrosine kinase receptor HER2 (erbB-2): from oncogenesis to adipogenesis. J Cell Biochem 2008; 105: 1147-52.

Sellahewa C, Nightingale P, Carmichael AR. Obesity and HER 2 overexpression: a common factor for poor prognosis of breast cancer. Int Semin Surg Oncol 2008; 5: 2.

Liu CL, Chang YC, Cheng SP, Chern SR, Yang TL, Lee JJ, Guo IC, Chen CP. The roles of serum leptin concentration and polymorphism in leptin receptor gene at codon 109 in breast cancer. Oncology 2007; 72: 75-81.

Phipps AI, Malone KE, Porter PL, Daling JR, Li CI. Body size and risk of luminal, HER2-overexpressing, and triple-negative breast cancer in postmenopausal women. Cancer Epidemiol Biomarkers Prev 2008; 17: 2078-86.

Stead LA, Lash TL, Sobieraj JE, et al. Triple-negative breast cancers are increased in black women regardless of age or body mass index. Breast Cancer Res 2009; 11: R18.

Vona-Davis L, Rose DP, Hazard H, Howard-McNatt M, Adkins F, Partin J, Hobbs G. Triple negative breast cancer and obesity in a rural Appalachian population. Cancer Epidemiol Biomarkers Prev 2008; 17: 3319-24.

Litton JK, Gonzalez-Angulo AM, Warneke CL, et al. Relationship between obesity and pathologic response to neoadjuvant chemotherapy among women with operable breast cancer. J Clin Oncol 2008; 26: 4072-7.

Greenman CG, Jagielski CH, Griggs JJ. Breast cancer adjuvant chemotherapy dosing in obese patients: dissemination of information from clinical trials to clinical practice. Cancer 2008; 112: 2159-65.

Darga LL, Magnan M, Mood D, Hryniuk WM, DiLaura NM, Djuric Z. Quality of life as a predictor of weight loss in obese, early-stage breast cancer survivors. Oncol Nurs Forum 2007; 34: 86-92.
Quick links
© 2018 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe